Name | ciglitazone |
---|---|
Synonyms |
Ciglitazone
UNII:U8QXS1WU8G ciglitazonum 2,4-Thiazolidinedione, 5-[[4-[(1-methylcyclohexyl)methoxy]phenyl]methyl]- CIGLITIZONE CIGLITLZONE MFCD00865499 5-[4-(1-methylcyclohexylmethoxy) benzyl]-thiazolidine-2,4-dione Flurofamide AD-4533 ciglitazona ADD 3878 5-{4-[(1-Methylcyclohexyl)methoxy]benzyl}-1,3-thiazolidine-2,4-dione Ciglitazone,5-[[4-[(1-Methylcyclohexyl)methoxy]phenyl]methyl]-2,4-thiazolidinedione |
Description | Ciglitazone is a potent and selective PPARγ agonist (EC50=3 μM). Ciglitazone inhibits proliferation and differentiation of th17 cells. Ciglitazone is a hypoglycemic agent orally active in the obese-hyperglycemic animal models. Ciglitazone induces apoptosis accompanied by activation of p38 MAPK and nuclear translocation of apoptosis inducing factor (AIF) in opossum kidney (OK) renal epithelial cells[1][2][3][4]. |
---|---|
Related Catalog | |
In Vitro | Ciglitazone (0-20 μM; 24 hours) induces apoptosis through PPAR-independent mechanism. Ciglitazone causes generation of ROS and an increase in intracellular Ca2+[4]. |
In Vivo | In C57BL/6J-ob/ob mice, Ciglitazone (100 mg/kg/day; 2 days) elicits a drastic fall in blood glucose. Regranulation of islet beta-cells and increased pancreatic insulin content are observed in ob/ob mice treated for 41-44 days with 100 mg/kg/day Ciglitazone[3]. |
References |
Density | 1.2±0.1 g/cm3 |
---|---|
Boiling Point | 504.5±23.0 °C at 760 mmHg |
Melting Point | 130-131ºC |
Molecular Formula | C18H23NO3S |
Molecular Weight | 333.445 |
Flash Point | 258.9±22.6 °C |
Exact Mass | 333.139862 |
PSA | 80.70000 |
LogP | 4.69 |
Vapour Pressure | 0.0±1.3 mmHg at 25°C |
Index of Refraction | 1.568 |
Storage condition | 2-8°C |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Personal Protective Equipment | Eyeshields;Gloves;half-mask respirator (US);multi-purpose combination respirator cartridge (US) |
---|---|
Hazard Codes | Xn |
RIDADR | NONH for all modes of transport |
WGK Germany | 3 |
RTECS | XJ5813700 |